Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
37
NKTR Quote, Financials, Valuation and Earnings
Last price:
$37.60
Seasonality move
:
-2.36%
Day range:
$35.40 - $38.29
52-week range:
$6.48 - $66.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
38.85x
P/B ratio:
7.66x
Volume:
674K
Avg. volume:
892.5K
1-year change:
181.71%
Market cap:
$651.9M
Revenue:
$98.4M
EPS (TTM):
-$4.56
Earnings Data
Next earnings date for NKTR
Mar 11
2026
Most recent earnings per share
-$1.87
Beat by $0.91
(Nov 6/2025)
Consensus Estimate
-$2.79
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NKTR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | $10.1M | -- | -- | -$2.59 | -- |
| 03/11/2026 | Q4 | $10.4M | -- | -- | -$2.90 | -- |
| 11/06/2025 | Q3 | $10.2M | $11.8M | -$1.87 | -$2.79 | $0.91 |
| 08/07/2025 | Q2 | $9.4M | $11.2M | -$2.95 | -$3.12 | $0.17 |
| 05/08/2025 | Q1 | $15.4M | $10.5M | -$0.24 | -$2.82 | $2.58 |
| 03/12/2025 | Q4 | $36.7M | $29.2M | $0.51 | -$2.93 | $3.43 |
| 11/07/2024 | Q3 | $18.3M | $24.1M | -$0.18 | -$3.09 | $2.92 |
| 08/08/2024 | Q2 | $17.5M | $23.5M | -$0.25 | -$3.01 | $2.76 |
| 05/09/2024 | Q1 | $15.3M | $21.6M | -$0.19 | -$3.08 | $2.89 |
| 03/04/2024 | Q4 | $21.4M | $23.9M | -$0.22 | -$2.94 | $2.72 |
| 11/07/2023 | Q3 | -- | $24.1M | -$0.24 | -- | -- |
| 08/08/2023 | Q2 | -- | $20.5M | -$0.27 | -- | -- |
| 05/09/2023 | Q1 | -- | $21.6M | -$0.73 | -- | -- |
| 02/28/2023 | Q4 | -- | $22M | -$0.32 | -- | -- |
| 11/03/2022 | Q3 | -- | $23.6M | -$0.31 | -- | -- |
| 08/04/2022 | Q2 | -- | $21.6M | -$0.85 | -- | -- |
| 05/05/2022 | Q1 | -- | $24.8M | -$0.49 | -- | -- |
| 02/28/2022 | Q4 | -- | $25M | -$0.79 | -- | -- |
| 11/04/2021 | Q3 | -- | $24.9M | -$0.70 | -- | -- |
| 08/05/2021 | Q2 | -- | $28.3M | -$0.69 | -- | -- |
| 05/06/2021 | Q1 | -- | $23.6M | -$0.68 | -- | -- |
| 02/25/2021 | Q4 | -- | $23.5M | -$0.65 | -- | -- |
| 11/05/2020 | Q3 | -- | $30M | -$0.61 | -- | -- |
| 08/06/2020 | Q2 | -- | $48.8M | -$0.45 | -- | -- |
| 05/07/2020 | Q1 | -- | $50.6M | -$0.78 | -- | -- |
| 02/27/2020 | Q4 | -- | $33.9M | -$0.64 | -- | -- |
| 11/06/2019 | Q3 | -- | $29.2M | -$8.43 | -- | -- |
| 08/08/2019 | Q2 | -- | $23.3M | -$9.48 | -- | -- |
| 05/08/2019 | Q1 | -- | $28.2M | -$10.32 | -- | -- |
| 02/28/2019 | Q4 | -- | $39.8M | -$0.57 | -- | -- |
| 11/07/2018 | Q3 | -- | $27.8M | -$0.56 | -- | -- |
| 08/08/2018 | Q2 | -- | $1.1B | $5.33 | -- | -- |
| 05/10/2018 | Q1 | -- | $38M | -$0.60 | -- | -- |
| 03/01/2018 | Q4 | -- | $95.5M | -$0.21 | -- | -- |
| 11/07/2017 | Q3 | -- | $152.9M | $0.37 | -- | -- |
| 08/08/2017 | Q2 | -- | $34.6M | -$0.39 | -- | -- |
| 05/09/2017 | Q1 | -- | $24.7M | -$0.42 | -- | -- |
| 03/01/2017 | Q4 | -- | $37.5M | -$0.28 | -- | -- |
| 11/03/2016 | Q3 | -- | $36.3M | -$0.32 | -- | -- |
| 08/03/2016 | Q2 | -- | $32.8M | -$0.36 | -- | -- |
| 05/03/2016 | Q1 | -- | $58.9M | -$0.14 | -- | -- |
Nektar Therapeutics Earnings Questions
-
How Much did Nektar Therapeutics Generate in Revenue Last Quarter?
Nektar Therapeutics reported $11.8M worth of top line sales in its most recent quarter.
-
Did Nektar Therapeutics Beat Earnings Last Quarter?
Nektar Therapeutics announced earnings per share of -$1.87 which represents a beat of analyst forecast a -$2.79 per share.
-
Is Nektar Therapeutics Profitable?
Nektar Therapeutics reported $11.6M that represents $0.61 per share over the last quarter.
-
What is the Analyst Consensus for Nektar Therapeutics EPS Next Year?
Nektar Therapeutics's earnings are forecast to decrease from -$8.68 per share to -$8.32 per share next year representing a decrease of -4.11%.
-
When is Nektar Therapeutics's Earnings Date?
Nektar Therapeutics's next earnings date is March 11, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
